|
1
|
Association between higher levels of serum estradiol and elevated levels of fibrin (fibrinogen) degradation products in late pregnancy following assisted reproductive technology treatment. Thromb Res 2020; 187:63-71. [DOI: 10.1016/j.thromres.2019.12.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2019] [Revised: 12/06/2019] [Accepted: 12/28/2019] [Indexed: 01/30/2023]
|
|
2
|
Reuwer AQ, Hoekstra M, Touraine P, Twickler MT, Goffin V. Is prolactin involved in the evolution of atherothrombotic disease? Expert Rev Endocrinol Metab 2012; 7:345-361. [PMID: 30780847 DOI: 10.1586/eem.12.23] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Cardiovascular diseases (CVDs) account for approximately 30% of all deaths globally. The most important cause of CVD is atherothrombosis, in other words, narrowing of the arteries as a result of the deposition of cholesterol and other lipoid substances within the arterial wall. Several endocrine disorders have been linked to this pathological state. Recent clinical and experimental studies have suggested that prolactin, a pleiotropic pituitary hormone, may potentially contribute to CVD, either through direct modulation of local cellular processes within atherosclerotic plaques/thrombi and/or through influencing conventional cardiovascular metabolic risk factors. However, the precise role of prolactin in the pathology of CVD remains largely unknown. Here, the authors speculate whether prolactin-lowering treatment may become a future therapeutic approach in patients with elevated prolactin levels and concomitantly presenting with coexisting vascular disease or a significantly elevated risk for premature atherothrombotic vascular disease. Awareness of these new developments may also change our clinical opinions about therapeutic strategies in patients with prolactinomas.
Collapse
Affiliation(s)
- Anne Q Reuwer
- a Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
- b Department of Internal Medicine, Tergooiziekenhuizen, 1201 DA Hilversum, The Netherlands.
| | - Menno Hoekstra
- c Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands
| | - Philippe Touraine
- d Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Endocrinology and Reproductive Medicine, Pôle Cœur Métabolisme, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
- e Université Pierre et Marie Curie, Site Pitié-Salpêtrière, Paris, France
- f INSERM, Unit 845, Faculty of Medicine, Research Center in Growth and Signaling, Team 'PRL/GH Pathophysiology', University Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Necker, Paris, France
| | - Marcel ThB Twickler
- a Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
- g Department of Endocrinology, Diabetology and Metabolic Disease, Antwerp University Hospital, Wilrijkstraat, Edegem, Belgium
| | - Vincent Goffin
- f INSERM, Unit 845, Faculty of Medicine, Research Center in Growth and Signaling, Team 'PRL/GH Pathophysiology', University Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Necker, Paris, France
| |
Collapse
|
|
3
|
Lanzetta P, Crovato S, Pirracchio A, Bandello F. Retinal arteriolar obstruction with progestogen treatment of threatened abortion. ACTA OPHTHALMOLOGICA SCANDINAVICA 2002; 80:667-8. [PMID: 12485292 DOI: 10.1034/j.1600-0420.2002.800621.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
PURPOSE To describe a case of a retinal arteriolar occlusion associated with progestogen treatment of threatened abortion. METHODS Case report. RESULTS A 30-year-old woman who had received a 2-week course of high dose intramuscular progestogen for a threatened abortion presented with a paracentral scotoma in her right eye and occlusion of a small arteriole adjacent to the macula. There were no major subsequent variations in haemostasis and pre-existing systemic diseases were excluded. CONCLUSIONS Retinal arteriolar occlusion may be associated with high dose progestogen-only therapy in pregnant women.
Collapse
Affiliation(s)
- Paolo Lanzetta
- Department of Opthalmology, University of Udine, Udine, Italy.
| | | | | | | |
Collapse
|